In the first newsletter in 2021 we want to present you three publications that are of special interest for the Cardiovascular Surgery Community.
The first one is the “2020 EACTS/ELSO/STS/AATS expert consensus on post-cardiotomy extracorporeal life support in adult patients”. This comprehensive document covers all aspects of postcardiotomy extracorporeal life support and is a valuable resource and guiding document for the treatment of patients with low cardiac output after cardiac surgery.
The second publication presents the two-year data from the ELEVATE Registry, an European and Middle East post-market registry on the Heart Mate 3 left ventricular assist device. This study presents a “real world population” of patients receiving the Heart Mate 2 LVAD.
The third publication we want to make you aware of are the 2020 ACC/AHA guidelines on the management of patients with valvular heart disease. In this new version of the ACC/AHA guidelines SAVR or TF TAVI is equally recommended already in patients of ≥65 years of age compared to the 2017 ECS guidelines that equally recommend SAVR or TF TAVI in patients ≥75 years of age.
On behalf of the Working Group nucleus,
Martin Czerny, Chairperson 2020-2022 and Roman Gottardi, Communication Coordinator 2020-2022